Product logins

Find logins to all Clarivate products below.


Rick Finch

Senior Vice President, Life Sciences and Healthcare

As Global Lead for Clarivate Life Sciences and Healthcare Consulting Services, Rick is responsible for trusted partnerships and customer success across all practice areas, including Discovery and Translational Sciences, Clinical and Regulatory, Market Access, New Product Planning, Commercial Strategy, HEOR and Technology Services.​

His focus is on helping executives improve decision making and accelerate execution in the areas of early stage scientific research, drug development, and commercialization. ​

Over the past 20+ years, Rick has worked with major pharmaceutical, digital advertising, high-tech, consumer goods and retail companies in areas such as product research and development, sales and marketing, operations, and information technology. During that time, he has led key transformation programs in analytics and data management, post-merger integration, product launch and support, new product development, digital sales and marketing, customer/patient centricity, and technology enablement.​

Prior to joining Clarivate in 2019, Rick was a Managing Director at Accenture, leading the sales and marketing consulting practice across Life Sciences, Consumer Goods and Retail. Rick has an M.Phil from the University of Oxford and a B.A. in History from Boston College.


arrow_forward
Get in touch with Rick

Latest news

Partner news June 25, 2026
LibTech Insights and Clarivate Announce “AI Essentials for Academic Libraries: Beyond the Basics”

Following the success of last year’s program, Clarivate and Choice team up once again to explore AI literacy topics in a three-part course June 25, 2026, Chicago, IL – Choice…

Partner news
News June 25, 2026
Clarivate and Healthcare Executive Unveil the 2026 Top 100 Most Innovative Chinese Pharmaceutical Companies

New ranking highlights the growing global influence of Mainland China’s pharmaceutical innovators London, U.K. June 25, 2026. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, and Healthcare Executive,…

News June 23, 2026
Clarivate Releases 2025 Sustainability Report

New report highlights progress against goals and a decline in total carbon emissions London, U.K. June 23 2026 — Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence,…

Related resources

Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech Bispecific antibodies BsAb Clinical trials Development Oncology Pharma R&D Regulatory Research
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Blog June 22, 2026
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Biopharma Biotech Clinical trials CMC Development R&D Real-World Data Regulatory Research Safety
Three uncomfortable truths about cell and gene therapy in regulatory affairs Three uncomfortable truths about cell and gene therapy in regulatory affairs
Blog May 28, 2026
Three uncomfortable truths about cell and gene therapy in regulatory affairs
Consulting Resource Center Regulatory
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.